LYRA: lyratherapeutics.com Amount of Cash per Share

Corporate emblem and logo of Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. (LYRA) is implementing green standards in biopharmaceuticals by reducing harmful emissions and energy costs. Business success relies on physician recognition of innovative rhinosinusitis treatment systems. Monitoring cash per share visualizes the balance between liquidity and investments, where the value 0.00 serves as the baseline indicator. The stability of the US jurisdiction and patent protection minimize any geopolitical risks for the issuer.

LYRA: Lyra Therapeutics Inc. Cash per Share 07/04/2022 - 03/28/2026

Analytical breakdowns for Lyra Therapeutics, Inc.

Summary company analysis:LYRA, Lyra Therapeutics Inc
Original product of lyratherapeutics.com

Cash per share determines the volume of liquid assets attributable to a single common share. An increase in this metric reduces debt risks, whereas stagnation may indicate inefficient capital management. By analyzing the cash per share chart, an investor assesses the issuer's financial stability. For Lyra Therapeutics, Inc. (LYRA), this reserve is critical due to FDA regulatory constraints. The current cash balance ensures the ecosystem's survival during the revision of LYR-210 trial protocols.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|Rani Therapeutics Holdings, Inc. - Cash Funds per Single Share|Cash Funds per Share Synergy CHC Corp. SNYR|Amount of Cash per Share RLYB|LEXX: Cash per Single Share|Amount of Cash per Share PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Cash Funds per Share|Cash per Single Share Aptorum|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)